高齢者の間で適度なアルコール摂取と心不全のリスク
J L Abramson1, S A Williams, H M Krumholz
1Emory University School of Medicine, Department of Medicine, Division of Cardiology, 1256 Briarcliff Rd NE, Suite 1 North, Atlanta, GA 30306, USA. jerome@ecor.cardio.emory.edu
JAMA
|April 20, 2001
まとめ
適度なアルコール摂取は,高齢者の心不全のリスク低下と関連しています. この発見は,他の健康要因と心筋梗塞 (MI) のリスクを考慮したとしても当てはまります.
科学分野:
- 心臓病学 心臓病学
- ゲリアトリクス ゲリアトリクス
- 公衆衛生は公衆衛生である.
背景:
- 過剰なアルコール摂取は,心不全の既知の危険因子です.
- 心不全のリスクに対する適度なアルコール摂取の影響は不明である.
研究 の 目的:
- 高齢者における適度なアルコール摂取と心不全のリスクとの関連性を調査する.
- この関連が心筋梗塞 (MI) リスクとは独立しているかどうかを判断する.
主な方法:
- 2235人の高齢者参加者を対象とした前向きなコホート研究で,最大14年間追跡調査が行われました.
- アルコールの消費量は,ベースライン前の1ヶ月の摂取量に基づいて評価されました.
- 心不全イベント (致命的または非致命的) は,主要なアウトカムとして追跡されました.
主要な成果:
- 適度なアルコール摂取量 (1〜70オンス/月) の増加は,心不全率の低下と関連していました.
- 心不全の調整された相対リスクは,非飲酒者に対して1.00,0.79,0.53,1〜20オンス,21〜70オンスであった.
- 適度なアルコール摂取量を増やすことで心不全のリスクが低下する傾向は,統計的に有意であった (P=.02).
結論:
- 適度なアルコール摂取は,高齢者の心不全のリスク低下と関連しています.
- この関連性は,いくつかの混同要因から独立しています.
- 心不全に対する保護効果は,単に心筋梗塞のリスクの低下によるものではないようです.
関連する概念動画
CNS Depressants: Alcohol and Nicotine
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Depressants
Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
Stress Prevention and Stress Management Techniques IV
Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...


